Skip to content

The Role of Nutrition in Muscle Function of Bariatric Surgery Patients

The Role of Nutrition in Muscle Function of Bariatric Surgery Patients

Status
Recruiting
Phases
Unknown
Study type
Observational
Source
ClinicalTrials.gov
Registry ID
NCT06680492
Enrollment
75
Registered
2024-11-08
Start date
2017-06-23
Completion date
2026-01-31
Last updated
2024-11-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Bariatric Surgery Patients, Body Composition Changes, Muscle Function, Handgrip Strength Test, Obesity, Diabetes, Nutrition, Physical Health, Protein Metabolism

Keywords

Obesity, Bariatric sugery, Protein function, Muscle function, 6-Minute Walk Test, Handgrip Strength Test, Nutritional needs, Nutritional guides, Nutrition

Brief summary

Current recommendations for protein intake after bariatric surgery are not based on strong scientific evidence. It remains unclear how much protein should be eaten to minimize muscle loss and preserve the metabolism and function of individuals post-bariatric surgery. The objective of this study is to analyze the relationships between changes in body composition, nutrition and protein intake, and muscle function after bariatric surgery to further our understanding of the nutritional needs of patients after bariatric surgery. We intend to recruit around 75 participants, men and women, aged between 18 and 65 years. Participants will be recruited from the Bariatric Surgery Clinic, McGill University Health Center.

Interventions

None listed

Sponsors

Montreal General Hospital
CollaboratorOTHER
Concordia University, Montreal
Lead SponsorOTHER

Study design

Observational model
OTHER
Time perspective
CROSS_SECTIONAL

Eligibility

Sex/Gender
ALL
Age
18 Years to 65 Years
Healthy volunteers
Yes

Inclusion criteria

* Male and female * Aged 18 to 65 years old * Undergoing first bariatric surgery (any type) * Diabetics and non-diabetics * Non-smokers and non-cannabis consumers

Exclusion criteria

* Pregnant and breastfeeding women * Individuals undergoing second bariatric surgery * Regular smokers and cannabis consumers * Current use of Ozempic (or Ozempic-like medication) and anti-psychotic meds * Limited physical mobility (using walking aids such as canes, walkers, or wheelchairs) and issues with hand resistance * Kidney disease, non-controlled / unstable hypertension and hypothyroidism, and any metabolic disease other than diabetes

Design outcomes

Primary

MeasureTime frameDescription
Change in weightBaseline (pre-operation), and at 3-months and 6-months post-operation.Overall weight loss (kg)
Change in BMIBaseline (pre-operation), and at 3-months and 6-months post-operation.Height and weight will be measured and combined to report BMI (kg/m\^2).
Change in fat massBaseline (pre-operation), and at 3-months and 6-months post-operation.Body composition is measured by dual-energy x-ray absorptiometry.
Change in overall body fat percentageBaseline (pre-operation), and at 3-months and 6-months post-operation.Body composition is measured by dual-energy x-ray absorptiometry.
Resting Energy ExpenditureBaseline (pre-operation), and at 3-months and 6-months post-operation.Resting energy expenditure will be measured in a fasted state by indirect calorimetry. The volume of oxygen and carbon dioxide and water vapor pressure will be taken into consideration to calculate the resting energy expenditure.
Substrate OxidationBaseline (pre-operation), and at 3-months and 6-months post-operation.Substrate oxidation will be measured in a fasted state by indirect calorimetry. The volume of oxygen, carbon dioxide, and water vapor pressure will be taken into consideration to calculate the respiratory exchange ratio.
Nurition and Protein IntakeBaseline (pre-operation), and at 3-months and 6-months post-operation.A 3-day food journal and a 24-hour food recall will measure the nutritional profile (protein intake). A 24-hour urine sample will be used to measure urinary nitrogen concentration.
Hormone and Inflammatory Marker AssaysBaseline (pre-operation), and at 3-months and 6-months post-operation.The inflammatory cytokines, chemokines, and adipokines in blood will be measured using Enzyme-Linked Immunosorbent Assay (ELISA).

Countries

Canada

Contacts

Primary ContactSylvia Santosa, PhD, R.D.
s.santosa@concordia.ca514-848-2424

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026